Bread-dodging Britons should be more European about their diet
If the British public and bread were in a relationship, now would be a good time for some couple's therapy.
In the past decade, attitudes towards bread have shifted. According to Mintel, 8 per cent of British adults now avoid gluten in their diet as part of a 'healthy lifestyle', rather than due to having a diagnosed digestive condition like coeliac disease, a wheat allergy or gluten intolerance.
Maybe they're on to something. Recent studies show that processed bread stuffed with additives has been associated with an increased risk of cardiovascular disease and death. Nutritionists also argue that bread can contribute to weight gain, and is less nutrient-dense and filling compared with other carbohydrates like sweet potatoes or brown rice.
But then again, maybe they aren't. The UK's life expectancy is currently 81.3 years, whereas European countries that haven't adopted the gluten-free fad are living longer – Spain's is 83.7, France's is 83.3, Greece's is 81.9 and Italy's is 83.7, according to 2023 figures.
Not only have these countries swerved the gluten-free dietary craze, but bread retains a central part of everyday life in all of these countries, according to our destination experts. Those in France, Spain, Italy and Greece offer some perspective:
Anthony Peregrine
I don't feel that the French are quite as worried about the killer threat posed by bread as are the British. In general, they still see food as a source of sustenance and pleasure rather than as a sub-branch of medical science.
Figures differ, but it seems that the French eat around 30 million baguettes a day, bought from supermarkets and (mainly) from the 32,000 retail bakeries, or 'boulangeries'.
For comparison, it's said that the average French person eats a little over 52kg of bread a year. The British figure is 37kg. The fact that, in 2022, the French baguette was accepted onto Unesco's 'intangible cultural heritage' list says a lot.
And, certainly, the boulangerie remains at the heart of village and town life. Each day, some 12 million people visit their local baker's, which are not merely France's favourite shops, but a key part of the national identity. If the baker's shop shuts, the village is dying.
Anne Hanley
For many elderly Italians, especially country types, the word for meals is 'companatico' – quite literally, the stuff that goes with bread. In fact for all Italians, pane is an integral part of the meal: you wouldn't think of eating – at home or out – without some on the table. It's essential for directing stray items onto your fork, and for mopping up all that sauce left on your plate.
But this doesn't mean that Italians today actually eat all that much bread. Per-head sales have plummeted from 84kg a head annually in 1980 to just 29kg in 2024 – not so much because of fads or gluten fixations but because it's no longer considered a staple: the folk memory of harsh days when sufficient bread was key to providing essential carbs has waned. Which isn't to say that coeliac disease and gluten intolerance – real and imagined – aren't a thing, as the range of gluten-free products on supermarket shelves proves. It's just a little less fretted over.
For most Italians bread remains a part of culinary culture. Each region has its own: Rome's rosetta, the chunky salt-free loaves of Umbria and Tuscany, Puglia's chewy, slow-risen Altamura bread. Only a small percentage of bread consumed is of the sliced and packaged supermarket type. And relatively little of it forms the basis of snacks, which are more likely to come in the shape of a slab of pizza rustica.
Marti Buckley
The idea of our daily bread has never rung truer than at mealtimes in Spain. It's the main event at breakfast, in the form of tosta and an indispensable part of both lunch and dinner. And not just in a 'bread roll next to a plate' kind of way – the two-inch hunk of sliced baguette is, along with the knife, spoon and fork, considered an essential piece of cutlery.
I have watched grown men falter without a piece of bread to assist in the eating process, used with the left hand to scoop food onto a spoon. As most food items are served in separate courses, it also serves to soak up any sauces and gravies in the absence of, say, mashed potatoes.
Perhaps its continued popularity for all-day consumption is due to the fact that Spanish flour typically has a lower gluten content than flour in the UK, which can make it easier to digest. In Spain, there is no sense that bread is unhealthy, and if anything, there is a rediscovery of bread's amazing versatility in the form of an upsurge in artisan sourdough breads and a recovery of traditional baking methods.
Heidi Fuller-Love
Enter any Greek taverna and (after the ceremonial laying of the paper tablecloth) you'll be served with a basket of soft yellow bread cut into doorstop-sized hunks perfect for soaking up the herby olive oil oozing from your choriataki Greek salad or mopping up the juices from a medley of slow-cooked meat dishes.
According to the Deipnosophistae, Athenaeus of Naucratis's discursive tome about the dining habits of his fellow scholars, back in 200AD Greeks had at least 72 different types of bread. Even today – from Crete's twice-cooked dakos barley rusks to Thessaloniki's ring-shaped, sesame-spotted koulouri – bread is an important staple; so much so that the Greeks have two different names for the floury stuff: 'artos', which is the ancient Greek word still seen on bakery signs, and the modern word 'psomi'.
It's also a vital element in every religious ritual or riotous festival: at Easter Greeks flock to the church to pick up domed loaves that have been blessed by the priest, while spicy braided Christopsomo buns are a popular treat at Christmas. Once perceived as an eccentric fad, gluten-free products are a growing trend, however – although a friend with intolerance issues complains that most tavernas seem to think 'gluten-free' just means 'without eggs'.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Los Angeles Times
8 hours ago
- Los Angeles Times
U.K. lawmakers vote to decriminalize abortion amid concern about the prosecution of women
LONDON — British lawmakers voted Tuesday to decriminalize abortion in England and Wales after a lawmaker argued that it was cruel to prosecute women for ending a pregnancy. The House of Commons approved an amendment to a broader crime bill that would prevent women from being criminally punished under an antiquated law. Labor MP Tonia Antoniazzi, the Labor member of Parliament who introduced one of the amendments, said the change was needed because police have investigated more than 100 women for suspected illegal abortions over the past five years, including some who suffered natural miscarriages and stillbirths. 'This piece of legislation will only take women out of the criminal justice system because they are vulnerable and they need our help,' she said. 'Just what public interest is this serving? This is not justice, it is cruelty and it has got to end.' The amendment passed 379-137. The House of Commons will now need to pass the crime bill, which is expected, before it goes to the House of Lords, where it can be delayed but not blocked. Under current law, doctors can legally carry out abortions in England, Scotland and Wales up to 24 weeks, and beyond that under special circumstances, such as when the life of the mother is in danger. Abortion in Northern Ireland was decriminalized in 2019. Changes in the law implemented during the COVID-19 pandemic allow women to receive abortion pills through the mail and terminate their own pregnancies at home within the first 10 weeks. That has led to a handful of widely publicized cases in which women were prosecuted for illegally obtaining abortion pills and using them to end their own pregnancies after 24 weeks or more. Anti-abortion groups opposed the measures, arguing it would open the door to abortion on demand at any stage of pregnancy. 'Unborn babies will have any remaining protection stripped away, and women will be left at the mercy of abusers,' said Alithea Williams, public policy manager for the Society for the Protection of Unborn Children, which describes itself as the U.K.'s biggest pro-life campaign group. The debate came after recent prosecutions have galvanized support to repeal parts of the 1861 Offences Against the Person Act. In one case, a mother of three was sentenced to more than two years in prison in 2023 for medically inducing an abortion about eight months into her pregnancy. Carla Foster, 45, was released about a month later by an appeals court that reduced her sentence. Judge Victoria Sharp said that case called for 'compassion, not punishment' and there was no useful purpose in jailing her. Last month, a jury acquitted Nicola Packer on a charge of unlawfully self-administering poison or a noxious thing with intent to procure a miscarriage. Packer, who took abortion medicine when she was about 26 weeks pregnant, testified that she did not know she had been pregnant more than 10 weeks. Supporters of the bill said it was a landmark reform that would keep women from going to prison for ending their pregnancy. 'At a time when we're seeing rollbacks on reproductive rights, most notably in the United States, this crucial milestone in the fight for reproductive rights sends a powerful message that our lawmakers are standing up for women,' said Louise McCudden of MSI Reproductive Choices. A second amendment that would have gone even further than Antoniazzi's proposal, barring the prosecution of medical professionals and others who help women abort their fetuses, did not get to a vote. A competing Conservative measure that would have required an in-person appointment for a pregnant woman to get abortion pills was defeated. Melley and Kirka write for the Associated Press.


Hamilton Spectator
9 hours ago
- Hamilton Spectator
UK lawmakers vote to decriminalize abortion amid concern about the prosecution of women
LONDON (AP) — British lawmakers voted Tuesday to decriminalize abortion in England and Wales after a lawmaker argued that it was cruel to prosecute women for ending a pregnancy. The House of Commons approved an amendment to a broader crime bill that would prevent women from being criminally punished under an antiquated law. Labour MP Tonia Antoniazzi, the Labour member of Parliament who introduced one of the amendments, said the change was needed because police have investigated more than 100 women for suspected illegal abortions over the past five years, including some who suffered natural miscarriages and stillbirths. 'This piece of legislation will only take women out of the criminal justice system because they are vulnerable and they need our help,' she said. 'Just what public interest is this serving? This is not justice, it is cruelty and it has got to end.' The amendment passed 379-137. The House of Commons will now need to pass the crime bill, which is expected, before it goes to the House of Lords, where it can be delayed but not blocked. Under current law, doctors can legally carry out abortions in England, Scotland and Wales up to 24 weeks, and beyond that under special circumstances, such as when the life of the mother is in danger. Abortion in Northern Ireland was decriminalized in 2019. Changes in the law implemented during the COVID-19 pandemic allow women to receive abortion pills through the mail and terminate their own pregnancies at home within the first 10 weeks. That has led to a handful of widely publicized cases in which women were prosecuted for illegally obtaining abortion pills and using them to end their own pregnancies after 24 weeks or more. Anti-abortion groups opposed the measures, arguing it would open the door to abortion on demand at any stage of pregnancy. 'Unborn babies will have any remaining protection stripped away, and women will be left at the mercy of abusers,' said Alithea Williams, public policy manager for the Society for the Protection of Unborn Children, which describes itself as the U.K.'s biggest pro-life campaign group. The debate came after recent prosecutions have galvanized support to repeal parts of the 1861 Offences Against the Person Act. In one case, a mother of three was sentenced to more than two years in prison in 2023 for medically inducing an abortion about eight months into her pregnancy. Carla Foster, 45, was released about a month later by an appeals court that reduced her sentence. Judge Victoria Sharp said that case called for 'compassion, not punishment' and there was no useful purpose in jailing her. Last month, a jury acquitted Nicola Packer on a charge of unlawfully self-administering poison or a noxious thing with intent to procure a miscarriage. Packer, who took abortion medicine when she was about 26 weeks pregnant, testified that she did not know she had been pregnant more than 10 weeks. Supporters of the bill said it was a landmark reform that would keep women from going to prison for ending their pregnancy. 'At a time when we're seeing rollbacks on reproductive rights, most notably in the United States, this crucial milestone in the fight for reproductive rights sends a powerful message that our lawmakers are standing up for women,' said Louise McCudden of MSI Reproductive Choices. A second amendment that would have gone even further than Antoniazzi's proposal, barring the prosecution of medical professionals and others who help women abort their fetuses, did not get to a vote. A competing Conservative measure that would have required an in-person appointment for a pregnant woman to get abortion pills was defeated.
Yahoo
10 hours ago
- Yahoo
Infectious Disease Testing Surges to $29B: Kalorama Report Highlights Molecular Breakthroughs and Point-of-Care Growth in IVD Market
ARLINGTON, Va., June 17, 2025 /PRNewswire/ -- Kalorama Information, a leading authority in healthcare market intelligence, has released the latest edition of its bimonthly publication, In Vitro Diagnostics Business Outlook. Now in its fourth year, the most recent issue is a comprehensive market briefing offering exclusive insights into the evolving landscape of infectious disease testing—one of the most dynamic sectors within the global in vitro diagnostics (IVD) market. Previous issues have covered key IVD topics including cardiac biomarkers, glucose testing, point-of-care testing, blood screening, clinical chemistry, molecular HLA testing, and more. According to the latest issue, the infectious disease testing market reached an estimated $29 billion in 2024, with COVID-19 testing accounting for 18% of total revenue, even as demand declines post-pandemic. Non-COVID point-of-care (POC) testing continued its upward trajectory, increasing by mid-single digits, and the segment remains a critical driver of diagnostic innovation globally. "The infectious disease testing market is highly concentrated in North American and European markets, with a combined share exceeding three-quarters of the global market," said Daniel Granderson, Senior Editor at Kalorama Information. "However, distribution is slowly shifting as emerging markets ramp up adoption of molecular platforms and POC innovations." The report highlights the growing impact of next-generation technologies, including alternative PCR methods, microarrays, NGS, and mass spectrometry. Instrument-automated analysis and miniaturized platforms are enabling broader deployment across physician offices, mobile health clinics, and even home settings—marking a transformational shift in test accessibility. Other key insights from this edition: Molecular diagnostics remain concentrated in developed countries but show new growth in Latin America, Southeast Asia, and Africa. Point-of-care testing is increasingly pivoting to non-COVID applications, such as respiratory panels, STIs, and antimicrobial resistance surveillance. Investment, M&A, and R&D activity remain robust across diagnostic segments, as companies reorient toward long-term growth drivers beyond pandemic response. A Strategic Resource for Healthcare Decision-Makers In Vitro Diagnostics Business Outlook delivers six issues annually, each exploring a high-value IVD market segment. It is designed for: Corporate strategy teams seeking growth forecasts and pipeline planning data R&D and innovation leads tracking platform adoption and market shifts Investors and financial analysts evaluating diagnostic business models and M&A targets Clinical lab leaders and health policy experts seeking diagnostic utilization trends and access insights Each issue includes: Market forecasts, growth rates, and share analysis Company and product profiles M&A and partnership tracking Geographic and regulatory trends Expert commentary and exclusive news analysis Order Now The full report can be purchased at: For purchase or custom consultation, contact:Sheri Davie, Sales About Kalorama Information Kalorama Information, part of Science and Medicine Group Inc., is a trusted publisher of market research exclusively focused on the healthcare industry. For over 25 years, Kalorama has delivered accurate, timely, and strategic intelligence to leaders in biotechnology, clinical diagnostics, in vitro diagnostics (IVD), pharmaceuticals, medical devices, and broader healthcare sectors. Originally launched in 1998, Kalorama Information quickly established itself as a premier source of insight into U.S. and global medical markets. Today, Kalorama remains a leading authority on healthcare market dynamics, with a particular emphasis on IVD. Kalorama is best known for its flagship title, The Worldwide Market for In Vitro Diagnostic Tests, an internationally recognized benchmark in the diagnostics field. Other reports published throughout the year cover these and other healthcare topics in greater detail. Our innovative approach to research, combined with deep industry expertise, has made Kalorama a go-to resource for top healthcare companies, strategic planners, investors, and media seeking authoritative market data and trends. With a singular focus on healthcare, Kalorama continues to shape informed decision-making across the industry through comprehensive, evidence-based analysis. Kalorama also works in coordination with other Science and Medicine Group brands, including BioInformatics, which focuses on life science markets and marketing, SDi, the leading source of information on the laboratory life science and analytical instrumentation industry and publisher of IBO, its twice-monthly newsletter, and IMV, which publishes reports and data on the medical imaging and clinical markets. For more information about Kalorama Information and other services offered by Science and Medicine Group, please visit our website. View original content to download multimedia: SOURCE Kalorama Information Sign in to access your portfolio